Pacific Biosciences Of California (PACB) returns
Pacific Biosciences Of California returns over 10 years
$1,000 invested in Pacific Biosciences Of California ten years ago was worth $305.75 at the close on October 30, 2026, with dividends reinvested: an average return of -11.2% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +9.9% | — | $1,099 | -0.9% |
| 3 months | +76.0% | — | $1,760 | +2.1% |
| Year to date | +39.3% | — | $1,393 | +11.7% |
| 1 year | +34.3% | — | $1,343 | +12.4% |
| 3 years | -63.4% | -28.4% | $366.38 | +88.5% |
| 5 years | -90.2% | -37.1% | $98.38 | +76.0% |
| 10 years | -69.4% | -11.2% | $305.75 | +316.6% |
Pacific Biosciences Of California return by calendar year
| Year | PACB | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +39.3% | +11.7% | +27.6% |
| 2025 | +2.2% | +17.7% | -15.5% |
| 2024 | -81.3% | +24.9% | -106.2% |
| 2023 | +19.9% | +26.2% | -6.3% |
| 2022 | -60.0% | -18.2% | -41.8% |
| 2021 | -21.1% | +28.7% | -49.9% |
| 2020 | +404.7% | +18.4% | +386.3% |
| 2019 | -30.5% | +31.2% | -61.8% |
| 2018 | +180.3% | -4.6% | +184.9% |
| 2017 | -30.5% | +21.7% | -52.2% |
| 2016 | -71.1% | +12.0% | -83.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: PACB financials
No forecast, no recommendation. This page describes Pacific Biosciences Of California from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.